No Data
No Data
Press Release: Taro to Release Full Year Results on May 20, 2024
Taro to Release Full Year Results on May 20, 2024 HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 15, 2024-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its finan
Express News | Leading Independent Proxy Advisory Firms Iss and Glass Lewis Recommend Taro Shareholders Vote “for” Taro Sun Pharma Merger
Press Release: Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger NEW YORK--(BUSINESS WIRE)--May 08, 2024-- Taro Pharmaceutical Industries Lt
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
Taro Pharmaceutical: If Merger Is Completed, Taro Will Become a Privately Held Co >TARO
Taro Pharmaceutical: If Merger Is Completed, Taro Will Become a Privately Held Co >TARO
Express News | Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger With Sun Pharmaceutical Industries Ltd.